Clinical Trials Directory

Trials / Sponsors / Aptinyx

Aptinyx

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
TerminatedSafety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD
PTSD
Phase 2 / Phase 32021-12-13
Active Not RecruitingNYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body De
Mild Cognitive Impairment, Mild Dementia, Parkinson Disease
Phase 22019-11-14
CompletedEfficacy and Safety of NYX-2925 in Subjects With Fibromyalgia
Fibromyalgia
Phase 22019-11-12
CompletedEfficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropat
Diabetic Peripheral Neuropathic Pain
Phase 22019-11-12
CompletedSafety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder
Post-Traumatic Stress Disorder
Phase 22019-01-25
CompletedEvaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia
Fibromyalgia
Phase 22017-08-14
CompletedEfficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropat
Diabetic Peripheral Neuropathy
Phase 22017-06-27
CompletedSafety, Tolerability, PK of Oral NYX-2925 in Healthy Volunteers
Healthy Volunteers
Phase 12016-07-01